ASSESSMENT OF TREG CELLS CD4+CD25+IN CHRONIC CIRRHOTIC LIVER DISEASE AND HEPATOCELLULAR CARCINOMA EGYPTIAN PATIENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

EL BASSUONI M.A.; OBADA M.A.; KORAH T.; EL SAYED S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2008 | Volume:8 | Issue:3 Page(s): 173-177

Download Full-Text

View:

385

Download:

358

Cites:

Information Journal Paper

Title

ASSESSMENT OF TREG CELLS CD4+CD25+IN CHRONIC CIRRHOTIC LIVER DISEASE AND HEPATOCELLULAR CARCINOMA EGYPTIAN PATIENTS

Author(s)

EL BASSUONI M.A. | OBADA M.A. | KORAH T. | EL SAYED S. | Issue Writer Certificate

Keywords

CD4+CD25+ TREG CELL

HCV

HEPATOCELLULAR CARCINOMA

LIVER CIRRHOSIS

Abstract

Background and Aims: Dysfunction of the host immune system in cancer patients can be due to a number of factors, including secretion of tumor-derived immunosuppressive factors or induction of immune tolerance against tumorspecific antigens. Several studies suggest that suppression of tumor-associated antigen reactivates lymphocytes by CD4+ CD25+ regulatory T (Treg) cells. This study was designed to evaluate whether CD4+CD25+ Treg cells in chronic liver disease and HEPATOCELLULAR CARCINOMA (HCC) patients exhibit an expanded Treg pool and to correlate it with liver tumor markers and grading. Methods: Blood samples were collected from 20 patients with cirrhotic liver disease (CLD), 15 HCC patients and 10 healthy control subjects. Alpha feto-protein (AFP), HBV and HCV antibodies were detected by EIA. HCV was confirmed by immunoblotting and RT-PCR. To evaluate HCC grading, abdominal ultrasound guided liver biopsy was done. Patients were categorized into moderately differentiated (grade II) and poorly differentiated (grade III) groups. Cytometric analysis of CD4+CD25+ Treg cells in PBMCs was performed using anti-CD3, anti-CD4, anti-CD25, anti-CD45RA, and IgGisotype control (FITC and PE). Results: Both CLD and HCC groups were 80% positive for HCV while only 20% of CLD and 11% of HCC patients were positive for HBV. The mean percentage of CD4+CD25+T cell population demonstrated a highly significant increase in comparing HCV to HCC patients [2.47±0.66 vs. 8.96±1.38 (P<0.001)] and when comparing both group to controls [1.15±0.5 (P<0.01)]. Nine HCC patients were in grade II while 6/15 were in grade III. Their mean CD4+CD25+ T cells percentage was 9.12±1.52 and 8.73±1.33, respectively. A negative correlation was found between mean CD4+CD25+ T cells percentage and AFP serum level in HCC patients (r=-0.923) while Treg cells with patients tumor grades (II and III) (r=0.474 and 0.582, respectively). CLD showed a significant correlation with AFP level (r= 0.962).Conclusions: Tumor specific Treg cells may limit the efficacy of anti-tumor response. Treg cells correlate properly with the unique marker AFP and with tumor grades. Better understanding of the underlying mechanism of Treg regulation or of the strategy for controlling Treg cells may lead to effective HCV immunotherapy and enhancing immunity against cancer.

Cites

No record.

References

No record.

Cite

APA: Copy

EL BASSUONI, M.A., OBADA, M.A., KORAH, T., & EL SAYED, S.. (2008). ASSESSMENT OF TREG CELLS CD4⁺CD25⁺IN CHRONIC CIRRHOTIC LIVER DISEASE AND HEPATOCELLULAR CARCINOMA EGYPTIAN PATIENTS. HEPATITIS MONTHLY, 8(3), 173-177. SID. https://sid.ir/paper/306181/en

Vancouver: Copy

EL BASSUONI M.A., OBADA M.A., KORAH T., EL SAYED S.. ASSESSMENT OF TREG CELLS CD4⁺CD25⁺IN CHRONIC CIRRHOTIC LIVER DISEASE AND HEPATOCELLULAR CARCINOMA EGYPTIAN PATIENTS. HEPATITIS MONTHLY[Internet]. 2008;8(3):173-177. Available from: https://sid.ir/paper/306181/en

IEEE: Copy

M.A. EL BASSUONI, M.A. OBADA, T. KORAH, and S. EL SAYED, “ASSESSMENT OF TREG CELLS CD4⁺CD25⁺IN CHRONIC CIRRHOTIC LIVER DISEASE AND HEPATOCELLULAR CARCINOMA EGYPTIAN PATIENTS,” HEPATITIS MONTHLY, vol. 8, no. 3, pp. 173–177, 2008, [Online]. Available: https://sid.ir/paper/306181/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops